novo nordisk cuts glp-1 drug prices for cash-paying customers. Nordisk, Eli Lilly cut costs under Medicare Eli Lilly cuts cash price

Annie Moore, an internal medicine doctor who is board-certified in obesity medicine and has extensive experience prescribing GLP-1 weight loss medications to her patients

As GLP1-RAs are more likely to be prescribed in patients who has weight to lose, perhaps, we might be getting some confounding effect from obesity

New patients typically start at the 2.5 mg starting dose by default, which can be low for individuals who have been on semaglutide in the past No live visit

Acknowledgements This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License ( which permits any non-commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made

Acknowledgements We thank OPEN Health Communications for their editorial and graphics support, as well as coordination during the manuscript development, which was funded by Novo Nordisk A/S

Rapid weight loss disrupts this balance